$TALK
Talkspace, Inc.

2022 Q2 Form 10-Q Financial Statement

#000095017022007572 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $29.84M $30.15M $29.17M
YoY Change -3.68% 11.02% 13.56%
Cost Of Revenue $15.30M $15.13M $13.20M
YoY Change 30.78% 54.16% 47.35%
Gross Profit $14.55M $15.02M $15.97M
YoY Change -24.57% -13.39% -4.53%
Gross Profit Margin 48.74% 49.82% 54.75%
Selling, General & Admin $30.04M $29.42M $40.65M
YoY Change -25.19% 18.34% 59.53%
% of Gross Profit 206.5% 195.85% 254.54%
Research & Development $5.576M $5.035M $3.896M
YoY Change 16.63% 69.87% 72.39%
% of Gross Profit 38.33% 33.52% 24.39%
Depreciation & Amortization $268.0K $429.0K $515.0K
YoY Change -45.64% -7.14% 35.88%
% of Gross Profit 1.84% 2.86% 3.22%
Operating Expenses $35.61M $36.23M $44.55M
YoY Change -23.98% 21.17% 60.6%
Operating Profit -$21.07M -$21.21M -$28.58M
YoY Change -23.56% 68.89% 159.56%
Interest Expense -$1.865M $869.0K $7.528M
YoY Change -602.31% -6943.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.93M -$20.34M -$21.05M
YoY Change -24.64% 59.77% 89.3%
Income Tax $89.00K $21.00K $18.00K
% Of Pretax Income
Net Earnings -$23.02M -$20.36M -$21.07M
YoY Change -24.37% 59.84% 89.26%
Net Earnings / Revenue -77.14% -67.53% -72.22%
Basic Earnings Per Share -$0.15 -$0.13
Diluted Earnings Per Share -$147.9K -$132.1K -$136.3K
COMMON SHARES
Basic Shares Outstanding 155.1M 154.0M 152.3M
Diluted Shares Outstanding 155.7M 154.1M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.6M $184.1M $198.3M
YoY Change -32.86% 1784.23% 16724.45%
Cash & Equivalents $166.6M $184.1M $198.3M
Short-Term Investments
Other Short-Term Assets $3.940M $5.039M $9.562M
YoY Change -8.75% 82.18% 531.16%
Inventory
Prepaid Expenses
Receivables $7.162M $6.312M $5.512M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $177.7M $195.5M $213.3M
YoY Change -31.41% 871.66% 931.73%
LONG-TERM ASSETS
Property, Plant & Equipment $623.0K $633.0K $624.0K
YoY Change 13.48% 34.11% 256.57%
Goodwill $6.134M $6.134M
YoY Change 0.0%
Intangibles $3.086M $3.436M
YoY Change -33.86%
Long-Term Investments
YoY Change
Other Assets $85.00K $82.00K $82.00K
YoY Change -13.27% -97.62%
Total Long-Term Assets $9.742M $9.935M $10.28M
YoY Change -12.2% -32.88% -15.74%
TOTAL ASSETS
Total Short-Term Assets $177.7M $195.5M $213.3M
Total Long-Term Assets $9.742M $9.935M $10.28M
Total Assets $187.5M $205.4M $223.6M
YoY Change -30.62% 488.26% 580.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.810M $9.490M $7.429M
YoY Change -33.58% -43.61% -5.97%
Accrued Expenses $9.093M $7.022M $12.56M
YoY Change -5.67% -11.76% 670.02%
Deferred Revenue $6.026M $7.186M
YoY Change 38.94%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.66M $25.75M $27.18M
YoY Change -14.82% -21.58% 32.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.554M $191.0K $86.00K
YoY Change 5567.35%
Total Long-Term Liabilities $5.554M $191.0K $86.00K
YoY Change 5567.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.66M $25.75M $27.18M
Total Long-Term Liabilities $5.554M $191.0K $86.00K
Total Liabilities $30.21M $29.14M $31.33M
YoY Change -55.53% -11.27% 52.93%
SHAREHOLDERS EQUITY
Retained Earnings -$191.9M -$171.5M
YoY Change 57.67%
Common Stock $15.00K $15.00K
YoY Change 1400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.3M $176.3M $192.3M
YoY Change
Total Liabilities & Shareholders Equity $187.5M $205.4M $223.6M
YoY Change -30.62% 488.26% 580.21%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$23.02M -$20.36M -$21.07M
YoY Change -24.37% 59.84% 89.26%
Depreciation, Depletion And Amortization $268.0K $429.0K $515.0K
YoY Change -45.64% -7.14% 35.88%
Cash From Operating Activities -$17.96M -$15.15M -$24.60M
YoY Change 29.17% 290.46% 64.64%
INVESTING ACTIVITIES
Capital Expenditures -$72.00K $88.00K -$41.00K
YoY Change -44.62% -72.41% -96.15%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$72.00K -$88.00K -$41.00K
YoY Change -44.62% -72.41% -100.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 132.0K 1.505M 34.00K
YoY Change -99.95% 108.45% -100.01%
NET CHANGE
Cash From Operating Activities -17.96M -15.15M -24.60M
Cash From Investing Activities -72.00K -88.00K -41.00K
Cash From Financing Activities 132.0K 1.505M 34.00K
Net Change In Cash -17.90M -13.73M -24.61M
YoY Change -107.51% 294.97% -10.81%
FREE CASH FLOW
Cash From Operating Activities -$17.96M -$15.15M -$24.60M
Capital Expenditures -$72.00K $88.00K -$41.00K
Free Cash Flow -$17.89M -$15.23M -$24.56M
YoY Change 29.87% 262.89% 76.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001803901
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39314
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
TALKSPACE, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4636604
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
284-7206
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
155116870
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
184127000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198256000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4706000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4918000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6312000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5512000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
5039000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9562000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
195478000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
213330000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
633000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
624000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3086000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3436000
CY2022Q1 us-gaap Goodwill
Goodwill
6134000
CY2021Q4 us-gaap Goodwill
Goodwill
6134000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000
CY2022Q1 us-gaap Assets
Assets
205413000
CY2021Q4 us-gaap Assets
Assets
223606000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9490000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7429000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6026000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7186000
CY2022Q1 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
10234000
CY2021Q4 talk Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12562000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
25750000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27177000
CY2022Q1 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
3195000
CY2021Q4 talk Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
4070000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
191000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86000
CY2022Q1 us-gaap Liabilities
Liabilities
29136000
CY2021Q4 us-gaap Liabilities
Liabilities
31333000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155104655
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155104655
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152862447
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152862447
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
15000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
368152000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
363788000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191890000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171530000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
176277000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
192273000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205413000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
223606000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30150000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27157000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
15129000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
9814000
CY2022Q1 us-gaap Gross Profit
GrossProfit
15021000
CY2021Q1 us-gaap Gross Profit
GrossProfit
17343000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5035000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2964000
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1776000
CY2021Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2077000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21408000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22251000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8010000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2608000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
36229000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
29900000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-21208000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12557000
CY2022Q1 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
869000
CY2021Q1 talk Interest And Debt Expense Income
InterestAndDebtExpenseIncome
-173000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20339000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12730000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-20360000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12738000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.93
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154083443
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13762205
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.134140
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
192273000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2063000
CY2022Q1 talk Restricted Stock Units Vested
RestrictedStockUnitsVested
-67000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2368000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-20360000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
176277000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-98898000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
797000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1513000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1513000
CY2022Q1 talk Warrant Issuance Cost And Change In Fair Value
WarrantIssuanceCostAndChangeInFairValue
875000
CY2021Q1 talk Warrant Issuance Cost And Change In Fair Value
WarrantIssuanceCostAndChangeInFairValue
-165000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
800000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1666000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4923000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1076000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2061000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7030000
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-1160000
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2878000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1837000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-447000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
105000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15146000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
125000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12738000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-109201000
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.134140
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-20360000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12738000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
429000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
462000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2368000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3879000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
319000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319000
CY2022Q1 talk Payment Of Deferred Issuance Costs
PaymentOfDeferredIssuanceCosts
0
CY2021Q1 talk Payment Of Deferred Issuance Costs
PaymentOfDeferredIssuanceCosts
-75000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2063000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
797000
CY2022Q1 talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
-558000
CY2021Q1 talk Payments For Employee Taxes Withheld Related To Restricted Stock Units Vested
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1505000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
722000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13729000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3476000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198256000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13248000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184527000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9772000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
12000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
5000
CY2021Q1 talk Payment Of Noncash Financing Deferred Issuance Costs
PaymentOfNoncashFinancingDeferredIssuanceCosts
2673000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
174000
CY2022Q1 talk Payment Of Noncash Financing Deferred Issuance Costs
PaymentOfNoncashFinancingDeferredIssuanceCosts
0
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152862447
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152862447
CY2022Q1 talk Payment Of Noncash Financing Issuance Of Warrant And Other Costs Related To The Credit Agreement
PaymentOfNoncashFinancingIssuanceOfWarrantAndOtherCostsRelatedToTheCreditAgreement
0
CY2021Q1 talk Payment Of Noncash Financing Issuance Of Warrant And Other Costs Related To The Credit Agreement
PaymentOfNoncashFinancingIssuanceOfWarrantAndOtherCostsRelatedToTheCreditAgreement
175000
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
400000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates its assumptions on an ongoing basis. The Company’s management believes that the estimates, judgment, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p>
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30150000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27157000
CY2022Q1 talk Increase In Revenue Reserve
IncreaseInRevenueReserve
1000000.0
CY2022Q1 talk Aged Receivables Wrote Off
AgedReceivablesWroteOff
1200000
CY2022Q1 talk Revenue Reserves
RevenueReserves
4700000
CY2022Q1 talk Aged Balances
AgedBalances
3400000
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
6000000.0
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
7200000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155104655
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155104655
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M1D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13623000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19494202
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.95
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M17D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19214000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1552395
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.61
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2164870
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.95
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
426122
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.06
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18455605
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.97
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14220000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
13432414
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.86
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
16200000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2368000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1513000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-20360000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12738000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154083443
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13762205
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.93
CY2021Q2 talk Conversion Of Stock Conversion Rate
ConversionOfStockConversionRate
1.134140
CY2022Q1 talk Accrued Employee Compensation
AccruedEmployeeCompensation
3135000
CY2021Q4 talk Accrued Employee Compensation
AccruedEmployeeCompensation
5988000
CY2022Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2791000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2680000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1096000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1303000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3212000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2591000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
10234000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12562000

Files In Submission

Name View Source Status
0000950170-22-007572-index-headers.html Edgar Link pending
0000950170-22-007572-index.html Edgar Link pending
0000950170-22-007572.txt Edgar Link pending
0000950170-22-007572-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
talk-20220331.htm Edgar Link pending
talk-20220331.xsd Edgar Link pending
talk-20220331_cal.xml Edgar Link unprocessable
talk-20220331_def.xml Edgar Link unprocessable
talk-20220331_htm.xml Edgar Link completed
talk-20220331_lab.xml Edgar Link unprocessable
talk-20220331_pre.xml Edgar Link unprocessable
talk-ex31_1.htm Edgar Link pending
talk-ex31_2.htm Edgar Link pending
talk-ex32_1.htm Edgar Link pending
talk-ex32_2.htm Edgar Link pending